跳至主要内容
临床试验/CTRI/2020/07/026510
CTRI/2020/07/026510尚未招募不适用

Clinical presentation, Treatment and Outcomes of COVID patients admitted at a Multi-specialty hospital in Chennai - COVID Registry.

Hindu Mission Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2020年7月17日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,000
试验地点
1
主要终点
Clinical Improvement

研究概览

简要总结

COVID-19 is an infectious disease caused by a newly discovered coronavirus which affects different people in different ways. Globally, this virus will continue to have a major impact on humans health. As the infected people will develop mild to moderate illness and recover without hospitalization, which includes symptoms such as fever, dry cough, and tiredness. However, older people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Some of the serious symptoms include difficulty breathing or shortness of breath, chest pain or pressure, loss of speech or movement, eventually resulting in death (in some cases). Though only four months have elapsed since the emergence of COVID-19 only a few treatments have received global wide attention. Physicians worldwide have administered numerous treatments off-label to treat COVID  but identifying the full range of treatment is decisive for the treating physicians. So due to the lack of a precise treatment plan, this registry study data will help to understand the nature of disease more and provide an effective treatment plan for COVID-19 in the long term.

研究设计

研究类型
Observational

入排标准

年龄范围
0.00 Month(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • •All hospitalized patients with COVID-
  • •Patients of any age groups (Child, Adult, and older adult) of either gender including minors and pregnant womens.
  • •Patients receiving any specific treatment for COVID-19 disease.

排除标准

  • •Suspected patients with COVID-19, not confirmed by the laboratory.
  • •Patients who refused to receive medical treatments.

结局指标

主要结局

Clinical Improvement

时间窗: 2 weeks

次要结局

  • RT-PCR negativity.(Reduction in inflammatory markers.)

研究者

申办方类型
Private hospital/clinic

研究点 (1)

Loading locations...

相似试验